4.8 Article

A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2

期刊

CELL REPORTS
卷 18, 期 13, 页码 3167-3177

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2017.03.003

关键词

-

资金

  1. American Brain Tumor Association
  2. American Association for Cancer Research(AACR)
  3. Basic Cancer Research
  4. NIH [NS057727, NS040511]
  5. DanaFarber Strategic Research Initiative
  6. Howard Hughes Medical Institute
  7. Kids' Brain Tumor Cure Foundation
  8. Medical Research Council [MC_PC_12009] Funding Source: researchfish

向作者/读者索取更多资源

During development of the vertebrate CNS, the basic helix-loop-helix (bHLH) transcription factor Olig2 sustains replication competence of progenitor cells that give rise to neurons and oligodendrocytes. A pathological counterpart of this developmental function is seen in human glioma, wherein Olig2 is required for maintenance of stem-like cells that drive tumor growth. The mitogenic/gliomagenic functions of Olig2 are regulated by phosphorylation of a triple serine motif (S10, S13, and S14) in the amino terminus. Here, we identify a set of three serine/threonine protein kinases (glycogen synthase kinase 3 alpha/beta [GSK3 alpha/beta], casein kinase 2 [CK2], and cyclin-dependent kinases 1/2 [CDK1/2]) that are, collectively, both necessary and sufficient to phosphorylate the triple serine motif. We show that phosphorylation of the motif itself serves as a template to prime phosphorylation of additional serines and creates a highly charged acid blob in the amino terminus of Olig2. Finally, we show that small molecule inhibitors of this forward-feeding phosphorylation cascade have potential as glioma therapeutics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据